1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Chin, Y.K.Y. Ma, L. King, G.F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking Biochem. Pharmacol. 1873-2968 158 60 72 10.1016/j.bcp.2018.08.038 30149017 Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target. 2018 10.2210/pdb5wlx/pdb pdb_00005wlx 4163.811 Kappa-theraphotoxin-Aa1a 1 syn polymer no yes GDCHKFLGWCRGEKDPCCEHLTCHVKHGWCVWDGTI(NH2) GDCHKFLGWCRGEKDPCCEHLTCHVKHGWCVWDGTIX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n citation citation_author database_2 pdbx_database_status pdbx_nmr_software repository Initial release Data collection Database references Data collection Database references Other 1 0 2018-08-01 1 1 2019-02-27 1 2 2023-06-14 _citation.journal_abbrev _citation.journal_id_CSD _citation.journal_id_ISSN _citation.journal_volume _citation.page_first _citation.page_last _citation.pdbx_database_id_DOI _citation.pdbx_database_id_PubMed _citation.title _citation.year _citation_author.name _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name Solution structure of kappa-theraphotoxin-Aa1a N RCSB Y RCSB 2017-07-28 REL REL REL REL 446523 Avicularia sample 1 37 Best stereochemical properties as judged by Molprobity 200 20 anisotropic 1 2D 1H-15N HSQC anisotropic 1 2D 1H-13C HSQC anisotropic 1 2D 1H-1H TOCSY anisotropic 1 2D 1H-1H NOESY 1 mM natural abundance 20 mM natural abundance 20 mM p31 7.4 0.05 pH 1 atm 298 K torsion angle dynamics 1 lowest energy 1 mM Kappa-theraphotoxin-Aa1a, 20 mM sodium phosphate, 95% H2O/5% D2O p31 95% H2O/5% D2O solution Guntert, Mumenthaler and Wuthrich refinement CYANA Guntert, Mumenthaler and Wuthrich structure calculation CYANA CCPN chemical shift assignment Analysis CCPN peak picking Analysis Bruker Biospin collection TopSpin Bruker Biospin processing TopSpin Guntert, Mumenthaler and Wuthrich chemical shift assignment CYANA 600 Bruker B GLY 1 n 1 GLY 1 A ASP 2 n 2 ASP 2 A CYS 3 n 3 CYS 3 A HIS 4 n 4 HIS 4 A LYS 5 n 5 LYS 5 A PHE 6 n 6 PHE 6 A LEU 7 n 7 LEU 7 A GLY 8 n 8 GLY 8 A TRP 9 n 9 TRP 9 A CYS 10 n 10 CYS 10 A ARG 11 n 11 ARG 11 A GLY 12 n 12 GLY 12 A GLU 13 n 13 GLU 13 A LYS 14 n 14 LYS 14 A ASP 15 n 15 ASP 15 A PRO 16 n 16 PRO 16 A CYS 17 n 17 CYS 17 A CYS 18 n 18 CYS 18 A GLU 19 n 19 GLU 19 A HIS 20 n 20 HIS 20 A LEU 21 n 21 LEU 21 A THR 22 n 22 THR 22 A CYS 23 n 23 CYS 23 A HIS 24 n 24 HIS 24 A VAL 25 n 25 VAL 25 A LYS 26 n 26 LYS 26 A HIS 27 n 27 HIS 27 A GLY 28 n 28 GLY 28 A TRP 29 n 29 TRP 29 A CYS 30 n 30 CYS 30 A VAL 31 n 31 VAL 31 A TRP 32 n 32 TRP 32 A ASP 33 n 33 ASP 33 A GLY 34 n 34 GLY 34 A THR 35 n 35 THR 35 A ILE 36 n 36 ILE 36 A NH2 37 n 37 NH2 37 A author_defined_assembly 1 monomeric none 100 0 3150 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N THR 22 A N THR 22 A O VAL 31 A O VAL 31 1 A CYS 18 -69.91 -175.28 1 A CYS 23 -53.15 104.72 1 A TRP 29 -171.12 141.48 2 A CYS 18 -69.80 -175.17 2 A CYS 23 -52.99 104.65 2 A TRP 29 -171.60 141.45 3 A PRO 16 -69.77 -171.62 3 A CYS 18 -69.82 -174.97 3 A CYS 23 -51.92 104.68 3 A TRP 29 -170.63 142.17 4 A PRO 16 -69.72 -173.77 4 A CYS 18 -69.95 -174.69 4 A CYS 23 -51.80 104.69 4 A TRP 29 -171.60 141.86 5 A PRO 16 -69.76 -174.46 5 A CYS 18 -69.98 -174.62 5 A CYS 23 -52.17 104.73 5 A TRP 29 -170.86 141.52 6 A PRO 16 -69.72 -174.07 6 A CYS 18 -69.97 -174.68 6 A CYS 23 -51.96 104.71 6 A TRP 29 -171.19 141.55 7 A PRO 16 -69.71 -171.13 7 A CYS 18 -69.88 -174.63 7 A CYS 23 -51.94 104.78 7 A TRP 29 -171.72 141.83 8 A LYS 14 -99.05 56.35 8 A CYS 18 -69.89 -175.37 8 A CYS 23 -53.85 104.61 8 A TRP 29 -170.58 141.52 9 A PRO 16 -69.78 -173.68 9 A CYS 18 -69.95 -174.74 9 A CYS 23 -51.81 104.66 9 A TRP 29 -171.72 141.57 10 A PRO 16 -69.68 -174.25 10 A CYS 23 -51.83 104.73 10 A TRP 29 -170.91 141.07 11 A PRO 16 -69.82 -173.23 11 A CYS 18 -69.92 -174.86 11 A CYS 23 -51.89 104.69 11 A TRP 29 -171.14 142.02 12 A LYS 14 -99.17 48.36 12 A PRO 16 -69.68 -176.88 12 A CYS 18 -69.93 -175.40 12 A CYS 23 -54.23 104.78 12 A TRP 29 -171.65 141.62 12 A ASP 33 -170.72 129.51 13 A PRO 16 -69.72 -174.53 13 A CYS 18 -69.95 -174.73 13 A CYS 23 -51.86 104.71 13 A TRP 29 -171.77 142.01 14 A PRO 16 -69.78 -173.06 14 A CYS 18 -69.89 -169.48 14 A CYS 23 -51.99 104.76 14 A TRP 29 -171.71 142.48 15 A LYS 14 -102.78 63.15 15 A CYS 18 -69.92 -175.26 15 A CYS 23 -53.07 104.75 15 A TRP 29 -171.83 141.65 16 A LYS 14 -101.82 55.14 16 A CYS 18 -69.83 -174.44 16 A CYS 23 -54.82 104.75 16 A TRP 29 -171.17 142.09 17 A PRO 16 -69.73 -174.84 17 A CYS 18 -69.92 -174.78 17 A CYS 23 -51.93 104.73 17 A TRP 29 -171.88 141.86 18 A LYS 14 -103.04 56.10 18 A CYS 18 -69.87 -174.34 18 A CYS 23 -53.84 104.60 18 A TRP 29 -171.69 142.29 19 A PRO 16 -69.85 -171.27 19 A CYS 23 -54.17 104.74 19 A TRP 29 -170.89 141.52 19 A ASP 33 -128.24 -57.07 20 A LYS 14 -108.13 67.44 20 A CYS 18 -69.90 -174.37 20 A CYS 23 -51.77 104.70 20 A TRP 29 -171.81 141.36 N Solution structure of kappa-theraphotoxin-Aa1a 1 N N disulf 2.000 A CYS 3 A SG CYS 3 1_555 A CYS 18 A SG CYS 18 1_555 disulf 2.000 A CYS 10 A SG CYS 10 1_555 A CYS 23 A SG CYS 23 1_555 disulf 1.999 A CYS 17 A SG CYS 17 1_555 A CYS 30 A SG CYS 30 1_555 covale 1.329 both A ILE 36 A C ILE 36 1_555 A NH2 37 A N NH2 37 1_555 TOXIN Spider toxins; Inhibitor cystine knot; Theraphotoxin, TOXIN 5WLX PDB 1 1 5WLX 1 37 5WLX 1 37 5WLX A 1 1 37 2 anti-parallel A LEU 21 A LEU 21 A THR 22 A THR 22 A VAL 31 A VAL 31 A TRP 32 A TRP 32